No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Term sheet and enterprise valuation

all good NBB, just had enough of don & his promo parade. 

Share
New Message
Please login to post a reply